BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2167339)

  • 21. Antifungal agents. Part II. The azoles.
    Terrell CL
    Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New antifungal agents.
    Graybill JR
    Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):402-12. PubMed ID: 2546775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy for opportunistic fungal infections: past, present and future.
    Stevens DA
    Indian J Cancer; 1995 Mar; 32(1):1-9. PubMed ID: 7558104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Itraconazole and fluconazole: new drugs for deep fungal infection.
    Warnock DW
    J Antimicrob Chemother; 1989 Sep; 24(3):275-7. PubMed ID: 2553654
    [No Abstract]   [Full Text] [Related]  

  • 26. Treating systemic fungal infections in AIDS patients. Prolonging life against the odds.
    Scheld WM
    Postgrad Med; 1990 Dec; 88(8):97-100, 103-4. PubMed ID: 2243831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penicillium marneffei infection in patients infected with human immunodeficiency virus.
    Supparatpinyo K; Chiewchanvit S; Hirunsri P; Uthammachai C; Nelson KE; Sirisanthana T
    Clin Infect Dis; 1992 Apr; 14(4):871-4. PubMed ID: 1315586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of fluconazole in cryptococcal meningitis.
    Jones PD; Marriott D; Speed BR
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):235S-238S. PubMed ID: 2556240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the treatment of systemic fungal infections.
    Walsh TJ
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azole antifungal drugs: old and new.
    Dismukes WE
    Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
    [No Abstract]   [Full Text] [Related]  

  • 31. [Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
    Eloy O; Joly V; Ghnassia JC; Carbon C; Yeni P
    Presse Med; 1992 May; 21(20):937-42. PubMed ID: 1322537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated histoplasmosis in an AIDS patient treated with itraconazole.
    Kell PD; Smith DE; Barton SE; Midgley J; Samarasinghe PL; Gazzard BG
    Genitourin Med; 1991 Aug; 67(4):342-4. PubMed ID: 1655628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.
    Berry AJ; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1992 Mar; 36(3):690-2. PubMed ID: 1622188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
    Denning DW; Tucker RM; Hanson LH; Stevens DA
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):602-7. PubMed ID: 2170480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents.
    Robinson PA; Knirsch AK; Joseph JA
    Rev Infect Dis; 1990; 12 Suppl 3():S349-63. PubMed ID: 2330489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
    Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
    Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
    N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
    Parente F; Cernuschi M; Rizzardini G; Lazzarin A; Valsecchi L; Bianchi Porro G
    Am J Gastroenterol; 1991 Dec; 86(12):1729-34. PubMed ID: 1962617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
    Tucker RM; Denning DW; Hanson LH; Rinaldi MG; Graybill JR; Sharkey PK; Pappagianis D; Stevens DA
    Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.